PL2520575T3 - Związek 1,3,4-oksadiazolo-2-karboksyamidowy - Google Patents
Związek 1,3,4-oksadiazolo-2-karboksyamidowyInfo
- Publication number
- PL2520575T3 PL2520575T3 PL10841060T PL10841060T PL2520575T3 PL 2520575 T3 PL2520575 T3 PL 2520575T3 PL 10841060 T PL10841060 T PL 10841060T PL 10841060 T PL10841060 T PL 10841060T PL 2520575 T3 PL2520575 T3 PL 2520575T3
- Authority
- PL
- Poland
- Prior art keywords
- oxadiazole
- carboxamide compound
- carboxamide
- compound
- Prior art date
Links
- -1 1,3,4-oxadiazole-2-carboxamide compound Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4245—Oxadiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2009297960 | 2009-12-28 | ||
| EP10841060.6A EP2520575B1 (en) | 2009-12-28 | 2010-12-28 | 1,3,4-oxadiazole-2-carboxamide compound |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2520575T3 true PL2520575T3 (pl) | 2017-05-31 |
Family
ID=44226607
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL10841060T PL2520575T3 (pl) | 2009-12-28 | 2010-12-28 | Związek 1,3,4-oksadiazolo-2-karboksyamidowy |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US8796320B2 (pl) |
| EP (1) | EP2520575B1 (pl) |
| JP (1) | JP5794922B2 (pl) |
| KR (1) | KR101778320B1 (pl) |
| CN (1) | CN102725287B (pl) |
| AU (1) | AU2010339271B2 (pl) |
| CA (1) | CA2785679C (pl) |
| EA (1) | EA022458B1 (pl) |
| ES (1) | ES2610248T3 (pl) |
| NZ (1) | NZ600837A (pl) |
| PL (1) | PL2520575T3 (pl) |
| TW (1) | TWI523851B (pl) |
| WO (1) | WO2011081205A1 (pl) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2781716A1 (en) | 2009-12-04 | 2011-06-09 | Sunovion Pharmaceuticals Inc. | Multicyclic thieno compounds and use thereof for the treatment of a neurological disorder |
| WO2012170867A1 (en) * | 2011-06-09 | 2012-12-13 | Rhizen Pharmaceuticals Sa | Novel compounds as modulators of gpr-119 |
| US9242969B2 (en) | 2013-03-14 | 2016-01-26 | Novartis Ag | Biaryl amide compounds as kinase inhibitors |
| UY36294A (es) | 2014-09-12 | 2016-04-29 | Novartis Ag | Compuestos y composiciones como inhibidores de quinasa |
| WO2017013270A1 (en) | 2015-07-23 | 2017-01-26 | Universite De Strasbourg | Use of leptin signaling inhibitor for protecting kidneys from patients having ciliopathy |
| WO2017083216A1 (en) * | 2015-11-12 | 2017-05-18 | Merck Sharp & Dohme Corp. | Cyanopyridine derivatives as liver x receptor beta agonists, compositions, and their use |
| SG10202100751YA (en) | 2016-07-29 | 2021-03-30 | Sunovion Pharmaceuticals Inc | Compounds and compositions and uses thereof |
| AU2017301769B2 (en) | 2016-07-29 | 2022-07-28 | Pgi Drug Discovery Llc | Compounds and compositions and uses thereof |
| WO2018051306A1 (en) | 2016-09-19 | 2018-03-22 | Novartis Ag | Therapeutic combinations comprising a raf inhibitor and a erk inhibitor |
| AU2018220509B2 (en) | 2017-02-16 | 2022-04-28 | Sumitomo Pharma America, Inc. | Methods of treating schizophrenia |
| WO2018187479A1 (en) | 2017-04-04 | 2018-10-11 | Case Western Reserve University | Method of modulating ribonucleotide reductase |
| KR20240032157A (ko) | 2017-05-02 | 2024-03-08 | 노파르티스 아게 | 병용 요법 |
| SG11202000669VA (en) | 2017-08-02 | 2020-02-27 | Sunovion Pharmaceuticals Inc | Isochroman compounds and uses thereof |
| CN109535146B (zh) * | 2017-09-21 | 2020-09-22 | 中国医学科学院医药生物技术研究所 | 抗结核化合物及其制备方法和用途 |
| CA3091292A1 (en) | 2018-02-16 | 2019-08-22 | Sunovion Pharmaceuticals Inc. | Salts, crystal forms, and production methods thereof |
| TWI826531B (zh) | 2018-09-21 | 2023-12-21 | 南韓商愛思開生物製藥股份有限公司 | 具有㗁二唑之化合物及包含該化合物之醫藥組合物 |
| TW202039481A (zh) | 2018-12-21 | 2020-11-01 | 美商西建公司 | Ripk2之噻吩并吡啶抑制劑 |
| US11447482B1 (en) | 2019-02-14 | 2022-09-20 | KUDA Therapeutics, Inc. | Imidazopyridine and oxazolopyridine derivatives and analogs thereof, methods of preparation thereof, methods of HIF-2A pathway inhibition, and induction of ferroptosis |
| JP7703449B2 (ja) | 2019-03-14 | 2025-07-07 | スミトモ・ファーマ・アメリカ・インコーポレイテッド | イソクロマニル化合物の塩およびその結晶体、ならびにそれらの製造方法、治療用途および医薬組成物 |
| JP2022527114A (ja) | 2019-04-05 | 2022-05-30 | カイメラ セラピューティクス， インコーポレイテッド | 分解剤およびそれらの使用 |
| MX2021013817A (es) | 2019-05-13 | 2021-12-14 | Novartis Ag | Nuevas formas cristalinas de n-(3-(2-(2-hidroxietoxi)-6-morfolinop iridin-4-il)-4-metilfenil)-2-(trifluorometil)isonicotinamida como inhibidores de raf para el tratamiento del cancer. |
| CN119431323A (zh) * | 2019-07-31 | 2025-02-14 | 贝林格尔·英格海姆国际有限公司 | 作为cd38抑制剂的杂双环酰胺 |
| EP4029860A4 (en) * | 2019-09-09 | 2023-08-23 | Elobix Ab | METHOD FOR PRODUCING A 1,5-BENZOTHIAZEPIN COMPOUND |
| CN115734785A (zh) | 2020-04-14 | 2023-03-03 | 桑诺维恩药品公司 | (S)-(4,5-二氢-7H-噻吩并[2,3-c]吡喃-7-基)-N-甲基甲胺用于治疗神经和精神方面的病症 |
| WO2022216930A1 (en) * | 2021-04-08 | 2022-10-13 | Virginia Commonwealth University | Novel mda-9 antagonist with anti-metastatic potential |
| EP4642779A1 (en) * | 2022-12-31 | 2025-11-05 | Nanjing Immunophage Biotech Co., Ltd | Compounds as inhibitors of macrophage migration inhibitory factor and the use thereof |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7429593B2 (en) * | 2001-09-14 | 2008-09-30 | Shionogi & Co., Ltd. | Utilities of amide compounds |
| ATE489384T1 (de) | 2002-05-06 | 2010-12-15 | Vertex Pharma | Thiadiazole oder oxadiazole und ihre verwendung als jak proteinkinaseinhibitoren |
| US7683097B2 (en) * | 2004-05-27 | 2010-03-23 | Propharmacon Inc. | Topoisomerase inhibitors |
| ATE502025T1 (de) * | 2004-10-19 | 2011-04-15 | Compass Pharmaceuticals Llc | Arylcarboxamide und ihre verwendung als antitumormittel |
| UA95978C2 (ru) | 2006-10-02 | 2011-09-26 | Оцука Фармас'Ютікел Ко., Лтд. | Ингибитор активации stat3/5 |
| EP3067054B1 (en) * | 2007-09-10 | 2020-12-30 | Boston Biomedical, Inc. | Novel compositions and methods for cancer treatment |
| US8642660B2 (en) * | 2007-12-21 | 2014-02-04 | The University Of Rochester | Method for altering the lifespan of eukaryotic organisms |
| CA2726987C (en) | 2008-06-04 | 2014-02-18 | Baylor College Of Medicine | Stat3 inhibitors |
| US8466290B2 (en) | 2008-07-10 | 2013-06-18 | Pharma Ip General Incorporated Association | STAT3 inhibitor containing quinolinecarboxamide derivative as active ingredient |
-
2010
- 2010-12-28 PL PL10841060T patent/PL2520575T3/pl unknown
- 2010-12-28 ES ES10841060.6T patent/ES2610248T3/es active Active
- 2010-12-28 US US13/519,707 patent/US8796320B2/en active Active
- 2010-12-28 NZ NZ600837A patent/NZ600837A/en not_active IP Right Cessation
- 2010-12-28 EP EP10841060.6A patent/EP2520575B1/en active Active
- 2010-12-28 AU AU2010339271A patent/AU2010339271B2/en not_active Ceased
- 2010-12-28 KR KR1020127016740A patent/KR101778320B1/ko not_active Expired - Fee Related
- 2010-12-28 CA CA2785679A patent/CA2785679C/en active Active
- 2010-12-28 WO PCT/JP2010/073787 patent/WO2011081205A1/ja not_active Ceased
- 2010-12-28 TW TW099146436A patent/TWI523851B/zh not_active IP Right Cessation
- 2010-12-28 CN CN201080059883.3A patent/CN102725287B/zh not_active Expired - Fee Related
- 2010-12-28 JP JP2011547732A patent/JP5794922B2/ja not_active Expired - Fee Related
- 2010-12-28 EA EA201290397A patent/EA022458B1/ru not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| CN102725287B (zh) | 2015-07-01 |
| TWI523851B (zh) | 2016-03-01 |
| KR20120109530A (ko) | 2012-10-08 |
| WO2011081205A1 (ja) | 2011-07-07 |
| AU2010339271A1 (en) | 2012-07-19 |
| ES2610248T3 (es) | 2017-04-26 |
| CA2785679C (en) | 2017-12-12 |
| CA2785679A1 (en) | 2011-07-07 |
| NZ600837A (en) | 2014-01-31 |
| JPWO2011081205A1 (ja) | 2013-05-13 |
| KR101778320B1 (ko) | 2017-09-13 |
| US8796320B2 (en) | 2014-08-05 |
| JP5794922B2 (ja) | 2015-10-14 |
| EA022458B1 (ru) | 2016-01-29 |
| EP2520575A4 (en) | 2013-12-11 |
| CN102725287A (zh) | 2012-10-10 |
| EA201290397A1 (ru) | 2013-01-30 |
| US20120302524A1 (en) | 2012-11-29 |
| EP2520575B1 (en) | 2016-11-30 |
| EP2520575A1 (en) | 2012-11-07 |
| TW201127832A (en) | 2011-08-16 |
| AU2010339271B2 (en) | 2015-09-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL2520575T3 (pl) | Związek 1,3,4-oksadiazolo-2-karboksyamidowy | |
| EP2361902A4 (en) | 4,6-DIAMINONICOTINSÄUREAMIDVERBINDUNG | |
| IL215615A0 (en) | Substituted 1-cyanoethylheterocyclylcarboxamide compounds 750 | |
| SI2384326T1 (sl) | Pirolo(2,3-d)pirimidinske spojine | |
| GB0913345D0 (en) | New combination 802 | |
| SI2356123T1 (sl) | Piro-5,6-dihidro-4h-2,3,5,10b-tetraaza-benzo(e)azuleni | |
| GB0804989D0 (en) | Compound | |
| SI2513119T1 (sl) | 3,4,4a,10b-tetrahidro-1H-tiopirano-(4,3-c)izokinolinski derivati | |
| GB201203224D0 (en) | Substitute 1,2-azaborne heterocycles | |
| GB0900404D0 (en) | New compounds 4 | |
| GB0803494D0 (en) | Compound | |
| IL214110A0 (en) | 2,3-diaryl-or heteroaryl-substituted 1,1,1-trifluoro-2-hydroxypropyl compounds | |
| IL207035A0 (en) | Benzylpiperizine compound | |
| SI2266990T1 (sl) | Spojina 3-fenilpirazolo(5,1-b)tiazola | |
| GB0912946D0 (en) | New compounds 5 | |
| AP2011005932A0 (en) | Pyrazinoisoquinoline Compounds. | |
| IL213762A0 (en) | 1,1,1-trifluoro-2-hydroxypropyl compounds | |
| GB201208654D0 (en) | Moisturing composition | |
| ZA201202652B (en) | Pesticidal compositions comprising 4,5-dihydroxyindan-1-one | |
| GB0823316D0 (en) | Compound | |
| GB0900385D0 (en) | Lasha2A.1 | |
| GB0918322D0 (en) | Compounds 814 | |
| GB0913344D0 (en) | Compounds 762 | |
| GB0912947D0 (en) | New compounds 6 | |
| GB0900400D0 (en) | New compounds 3 |